May 2009

Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)

Condition:   Chronic Lymphocytic Leukemia
Interventions:   Drug: Lenalidomide;   Drug: Fludarabine;   Drug: Rituximab;   Drug: Thymoglobulin;   Procedure: Stem Cell Transplantation;   Drug: Bendamustine;   Drug: Allopurinol
Sponsors:   M.D. Anderson Cancer Center;   Celgene Corporation
Active, not recruiting - verified May 2016

Al Pettit makes the news!

Our fearless moderator has made the news once again. Take a moment to read the Brampton Guardian's profile of Al Pettit.

The fight against ALS is far from over for Orangeville resident Al Pettit (our fearless moderator). In 2003, 59-year-old retired firefighter was officially diagnosed with amyotrophic lateral sclerosis, an incurable neurogenerative disease that causes progressive paralyzation.